Actively Recruiting
Study on the Safety and Effectiveness of the Micra AV2 Leadless Pacemaker for High-Degree AV Block Patients
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-01-21
150
Participants Needed
1
Research Sites
83 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the Micra AV2, a third-generation leadless pacemaker designed to improve heart rhythm control in patients with high-degree atrioventricular AV block and normal sinus rhythm. This study aims to assess the devices ability to maintain AV synchrony, especially during exercise, and to monitor its safety and effectiveness over time in real-world use. The study is a prospective, single-arm, multi-center clinical trial involving patients implanted with the Micra AV2 device. All participants will receive the Micra AV2 leadless pacemaker, which features new algorithms to enhance AV synchrony at higher heart rates compared to previous models. The device also offers a potential battery life extension of over 44%. The study will follow patients for up to three years, with key evaluations at 6 and 12 months post-implant to assess AV synchrony during daily activities and exercise, as well as left ventricular function. The implant procedure is the same for all participants. Participants will undergo scheduled follow-ups to monitor heart rhythm synchronization and device performance, including assessments at 6 months for AV synchrony and exercise response, and at 12 months for heart function changes. Long-term follow-up will evaluate the need for device revisions and monitor for complications such as pacing-induced heart issues. Safety and device efficacy will be continuously assessed throughout the study period, which extends until 2029.
CONDITIONS
Brief Title
Efficacy and Safety of Micra AV2 Transcatheter Pacing System
Research Team
C
Christophe Y Garweg, Professor
C
Caroline Devooght, Miss
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here